cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Stockal+Disclaimer.pdf
5 own
17 watching
Current Price
$1.32
$0.06
(4.76%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
68.94M
52-Week High
52-Week High
7.97000
52-Week Low
52-Week Low
1.21000
Average Volume
Average Volume
0.05M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization68.94M
icon52-Week High7.97000
icon52-Week Low1.21000
iconAverage Volume0.05M
iconDividend Yield--
iconP/E Ratio--
What does the Stockal+Disclaimer.pdf do?
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
Business Wire
12 months ago
Apyx Medical Corporation (NASDAQ:APYX) (the Company), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the use of the Renuvion APR...
Ticker Report
1 year ago
Apyx Medical (NASDAQ:APYX Get Rating) and Nyxoah (NASDAQ:NYXH Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, valuation, ...
TipRanks Financial Blog
1 year ago
Theres a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Miromatrix Medical (MIRO Research Report) and Apyx... Theres a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Miromatrix Medical (MIRO Research Report) and Apyx ...
Business Wire
1 year ago
Apyx Medical Corporation (NASDAQ:APYX) (the Company), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the use of the Renuvion APR...
Business Wire
1 year ago
Apyx Medical Corporation (NASDAQ:APYX) (the Company), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion, today announced that financial results for the fourth quarter and fiscal year 2022 will be released before the market opens on Thursday...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$1.32
$0.06
(4.76%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00